The above data represents the market value of Apollo Hospital.

The discount rate is 7.32%, which is used to calculate the present value of future cash flows.

The market premium is 6.68%, which represents the additional return expected by investors for taking on the risk of investing in the stock market.

The risk-free rate is 4.34%, which is the return expected from a risk-free investment such as a government bond.

The beta is 0.462, which measures the stock’s sensitivity to market movements.

The growth in perpetuity is 4.34%, which represents the expected long-term growth rate of the company.

The projection years are 5, which indicates the number of years for which future cash flows are projected.

The historical years are 10, which represents the number of years of past financial data used for analysis.

The revenue regression slope is 1, which suggests a linear relationship between revenue and time.

The operating cash flow margin is 9.02%, which indicates the percentage of revenue that is converted into operating cash flow.

The capital expenditure margin is 8.26%, which represents the percentage of revenue that is spent on capital expenditures.

The terminal value is 57,147 Mil.INR, which represents the estimated value of the company beyond the projection years.

The discounted terminal value is 40,142 Mil.INR, which is the present value of the terminal value.

The sum of discounted free cash flow is 6,215 Mil.INR, which represents the present value of the projected cash flows.

The enterprise value is 46,356 Mil.INR, which represents the total value of the company’s operations.

The cash and equivalents are 12,142 Mil.INR, which represents the company’s cash reserves.

The total debt is 43,324 Mil.INR, which represents the company’s outstanding debt.

The equity value is 15,175 Mil.INR, which represents the value of the company’s equity.

The estimated value per share is 105.568 INR, which represents the estimated value of each share of the company’s stock.

The yield of the U.S. 10 Year Treasury Note is 4.34%, which represents the return expected from investing in the U.S. government bond.

The average cash from operating activities margin is 9.02%, which represents the average percentage of revenue converted into operating cash flow over the historical years.

The average capital expenditure margin is 8.26%, which represents the average percentage of revenue spent on capital expenditures over the historical years.

The cost of equity is 7.43%, which represents the return required by equity investors to compensate for the risk of investing in the company.

The equity weight is 94.24%, which represents the percentage of the company’s value that is attributed to equity.

The cost of debt is 9.1%, which represents the return required by debt investors to compensate for the risk of lending to the company.

The debt weight is 5.76%, which represents the percentage of the company’s value that is attributed to debt.

The tax rate is 37.82%, which represents the percentage of income that is paid in taxes.

Overall, the data suggests that Apollo Hospital has a positive market value and is expected to generate positive cash flows in the future. The company’s financial performance, as indicated by the historical data, is relatively stable with consistent cash flow margins. The estimated value per share indicates a potential upside for investors. However, the company has a significant amount of debt, which may increase the risk for investors.